Commands a premium valuation multiple over its peers, likely pricing in superior execution.
Fragile underlying quality score of 38/100; weak margins or elevated debt leverage warrant caution.
Analysts remain bullish, forecasting further upside expansion with consensus targets suggesting solid gains.
Verdict: Mixed fundamental profile with offsetting strengths and weaknesses.
Wall Street is highly bullish, projecting significant upside alongside robust expected earnings growth. This is paired with healthy capital returns, driven by a balanced mix of reliable dividends and share buybacks.
RVSB struggles with subpar profitability and pressured margins. This is paired with a moderately leveraged but stable balance sheet.
The company maintains stable top-line performance paired with stable bottom-line earnings. However, profitability remains a major concern with severely compressed operating margins (-9.0%).
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $7.3M | -11.6% | — | — | +4.8% | |
| EBITDA | -$10.5M | — | — | — | — | |
| Net Income | -$8.0M | -188.5% | — | — | — | |
| EPS (Diluted) | $-0.39 | -191.3% | — | — | — | |
| Free Cash Flow | -$3.6M | +102.5% | +9.3% | -11.4% | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 64.6% | 68.6% | 80.5% | 86.4% |
| Operating Margin | -9.0% | 2.1% | 17.3% | 23.4% |
| Net Margin | -6.7% | 1.9% | 13.4% | 17.3% |
| FCF Margin | 17.4% | 11.9% | 13.9% | 21.4% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q2'26Latest | $0.05 | $0.03 | -40.0% | ||
| Q1'26 | $0.04 | $0.07 | +75.0% | ||
| Q4'25 | $0.06 | $0.05 | -16.7% | ||
| Q3'25 | $0.05 | $0.06 | +20.0% | ||
| Q2'25 | — | $0.05 | — | ||
| Q2'25 | $0.03 | $0.05 | +66.7% | ||
| Q1'25 | $0.04 | $0.06 | +50.0% | ||
| Q4'24 | $0.04 | $0.07 | +75.0% |
Total return is -5.1% (1Y), lagging the benchmark by -16.5%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | +6.3% | +5.3% | — |
| 1Y | -5.1% | -16.5% | +1.4% |
| 3YCAGR | +6.8% | -12.5% | +7.7% |
| 5YCAGR | -0.6% | -11.4% | +12.4% |
| 10YCAGR | +4.3% | -9.1% | — |
The S&P 500 is at 31.4x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about Riverview Bancorp, Inc. (RVSB) valuation, health, and returns.
Based on peer relative multiples, Riverview Bancorp, Inc. appears Slightly expensive versus peers compared to industry peers.
Riverview Bancorp, Inc. has multiple valuation anchors: Peer Relative Fair Value: $4.91 | Wall Street Analyst Target: $8.00 (implying +50.1% upside). A convergence of these signals offers higher conviction.
Riverview Bancorp, Inc. displays weak financial health with a composite quality score of 38/100, supported by a Piotroski F-Score of 5/9, Return on Invested Capital (ROIC) of -1.9%.
Riverview Bancorp, Inc. pays a 1.5% dividend yield, covered by a 0% payout ratio with 0 years of growth, supplemented by a 2.5% buyback yield.
Riverview Bancorp, Inc.'s current growth trajectory is Stable. The company achieved -11.6% 1Y revenue growth and -191.3% 1Y EPS growth, compared to its 3Y revenue CAGR of N/A.
Wall Street consensus is Sell based on 3 analysts, beating EPS expectations in 42% of recent quarters with a -1-quarter streak. The consensus price target represents a +50.1% change from current levels.
Investment risks for Riverview Bancorp, Inc. include: -16.2% 1-year max drawdown. Volatility risk is characterized by a beta of 0.37x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.